The conversation around weight loss and its associated stigma has taken an intriguing turn with the rise of GLP-1 medications like Ozempic and Wegovy. While these drugs have gained popularity for their potential to facilitate significant weight loss, a recent study from Rice University has revealed a surprising and somewhat unsettling social dynamic.
The Unexpected Stigma
Erin Standen, an assistant professor of psychological sciences at Rice, led a study published in the International Journal of Obesity, which uncovered a hidden cost of using GLP-1 medications. The research team, including Sean Phelan and Janet Tomiyama, found that individuals who use these medications often face greater judgment and stigma compared to those who don't lose weight at all.
This finding challenges the notion that weight loss automatically removes social bias. Instead, it suggests that the journey towards a healthier weight is riddled with potential pitfalls of judgment at various stages.
Shifting Judgment, Unchanged Stigma
The study's participants evaluated fictional individuals based on their weight history, and a clear pattern emerged. Those who lost weight through traditional methods, such as diet and exercise, were viewed more positively than GLP-1 users. Even more surprisingly, the GLP-1 users were rated more negatively than individuals who hadn't lost weight at all.
"The GLP-1 users were socially penalized not just compared to someone who lost weight through diet and exercise," Standen explained. "They were also rated more harshly than someone who didn't lose weight in the first place."
This shift in judgment highlights a complex social perception of weight loss and management. It suggests that while weight loss may change physical appearance, it doesn't necessarily eliminate the underlying stigma.
The Regain Conundrum
The study also explored the social consequences of weight regain, a common scenario among those who discontinue GLP-1 medications due to cost, insurance limitations, or side effects. Participants viewed individuals who regained weight more negatively than those who maintained their weight loss, regardless of whether the initial weight loss was medication-induced or through lifestyle changes.
"There's a lot of stigma tied to weight regain in general," Standen noted. "And that doesn't seem to depend much on how the weight was lost in the first place."
Beyond Social Attitudes
The implications of this research extend beyond social attitudes. Weight stigma has been consistently linked to negative mental and physical health outcomes, including stress, avoidance of medical care, and unhealthy coping strategies. Standen emphasizes that if individuals feel judged for their health choices, it can influence their willingness to seek care and manage their health effectively.
As GLP-1 medications become more mainstream, understanding these social effects is crucial. "This is a moment where these treatments are really entering the mainstream," Standen said. "So, understanding the social side of that is critical."
Towards a Stigma-Free Approach
Standen's research is part of a broader effort to encourage healthier choices without reinforcing stigma. Her goal is to understand how people can be supported without feeling judged. She highlights the strong cultural scripts around weight and the idea of a 'healthy' body, which often interfere with individuals making choices that are best for their unique circumstances.
"Ultimately, any form of stigma related to someone's body or their health choices is not helpful," Standen concluded. "People should be able to make decisions that are right for them without fear of being judged."
This research invites us to reflect on our own perceptions and biases, and to consider how we can create a more supportive and understanding environment for those navigating their health journeys.
